Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Soared Today

TheMotleyFool

0 0

Why Moderna Stock Soared TodayPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Shares of Moderna (NASDAQ: MRNA) surged 10% on Thursday after analysts at Bank of America issued a more optimistic outlook for the biotech company.

Bank of America analyst Geoff Meacham boosted his price forecast for Moderna's stock to $150 from $105. Meacham now believes that the drugmaker's COVID-19 vaccine could be worth as much as $78 per share, up from his previous estimate of $38.

A phase 3 study of Moderna's vaccine candidate, mRNA-1273, demonstrated a 94.1% efficacy rate against COVID-19. Health researchers were also impressed that the drug appears to be 100% effective at preventing severe forms of the disease.

Source Fool.com

Like: 0

MRNA

Share